Nath Bio-Genes Faces Evaluation Shift Amid Declining Institutional Interest and Profitability Challenges
Nath Bio-Genes (India) has recently experienced a revision in its evaluation due to changes in technical trends. The company has faced challenges, including a decline in institutional investor participation and underperformance compared to the BSE500 index, while trading at a discount relative to its peers.
Nath Bio-Genes (India), operating within the Other Agricultural Products sector, has recently undergone an adjustment in evaluation, reflecting a revision in its score. This change is attributed to a shift in technical trends, moving from bearish to mildly bearish. The company's current price stands at 171.30, with a previous close of 175.20. Over the past year, Nath Bio-Genes has experienced a return of -18.04%, significantly underperforming compared to the BSE500 index. In terms of long-term performance, the company has recorded a -0.69% CAGR growth in operating profits over the last five years, indicating challenges in sustaining profitability.
Institutional investor participation has also seen a decline, with a 1.5% reduction in their stake, now collectively holding 2.66% of the company. Despite these challenges, the stock is trading at a discount relative to its peers, with a price-to-book value of 0.5, suggesting a potentially attractive valuation.
Overall, the recent evaluation adjustment reflects the complexities surrounding Nath Bio-Genes' market position and performance indicators.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
